APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Drug Discovery

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Intelligence in Drug Discovery Market Outlook and Growth Opportunities 2026

6 January 2026211 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Drug Discovery Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Drug Discovery Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Drug Discovery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Drug Discovery Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Drug Discovery Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Drug Discovery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Intelligence in Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence in Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence in Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Intelligence in Drug Discovery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Intelligence in Drug Discovery market include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artificial Intelligence in Drug Discovery market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence in Drug Discovery and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence in Drug Discovery revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence in Drug Discovery market.

Artificial Intelligence in Drug Discovery Segment by Company

IBM

Exscientia

Google(Alphabet)

Microsoft

Atomwise

Schrodinger

Aitia

Insilico Medicine

NVIDIA

XtalPi

BPGbio

Owkin

CytoReason

Deep Genomics

Cloud Pharmaceuticals

BenevolentAI

Cyclica

Verge Genomics

Valo Health

Envisagenics

Euretos

BioAge Labs

Iktos

BioSymetrics

Evaxion Biotech

Aria Pharmaceuticals, Inc

Artificial Intelligence in Drug Discovery Segment by Type

Hardware

Software

Service

Artificial Intelligence in Drug Discovery Segment by Application

Early Drug Discovery

Preclinical Phase

Clinical Phase

Regulatory Approval

Artificial Intelligence in Drug Discovery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Intelligence in Drug Discovery status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Intelligence in Drug Discovery key companies, revenue, market share, and recent developments.

3. To split the Artificial Intelligence in Drug Discovery breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Intelligence in Drug Discovery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Intelligence in Drug Discovery significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Intelligence in Drug Discovery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Drug Discovery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence in Drug Discovery industry.

Chapter 3: Detailed analysis of Artificial Intelligence in Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Intelligence in Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Intelligence in Drug Discovery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Intelligence in Drug Discovery Industry Trends Table 2. Artificial Intelligence in Drug Discovery Industry Drivers Table 3. Artificial Intelligence in Drug Discovery Industry Opportunities and Challenges Table 4. Artificial Intelligence in Drug Discovery Industry Restraints Table 5. Global Artificial Intelligence in Drug Discovery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Intelligence in Drug Discovery Revenue Share by Company (2021-2026) Table 7. Global Artificial Intelligence in Drug Discovery Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Intelligence in Drug Discovery Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Intelligence in Drug Discovery Company, Product Type & Application Table 10. Global Artificial Intelligence in Drug Discovery Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Intelligence in Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hardware Table 15. Significant Companies of Software Table 16. Significant Companies of Service Table 17. Global Artificial Intelligence in Drug Discovery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Artificial Intelligence in Drug Discovery Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Artificial Intelligence in Drug Discovery Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Artificial Intelligence in Drug Discovery Sales Value Share by Type (2021-2026) Table 21. Global Artificial Intelligence in Drug Discovery Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Early Drug Discovery Table 23. Significant Companies of Preclinical Phase Table 24. Significant Companies of Clinical Phase Table 25. Significant Companies of Regulatory Approval Table 26. Global Artificial Intelligence in Drug Discovery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Artificial Intelligence in Drug Discovery Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Artificial Intelligence in Drug Discovery Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Artificial Intelligence in Drug Discovery Sales Value Share by Application (2021-2026) Table 30. Global Artificial Intelligence in Drug Discovery Sales Value Share by Application (2027-2032) Table 31. Global Artificial Intelligence in Drug Discovery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Artificial Intelligence in Drug Discovery Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Artificial Intelligence in Drug Discovery Sales Value Share by Region (2021-2026) Table 34. Global Artificial Intelligence in Drug Discovery Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Artificial Intelligence in Drug Discovery Sales Value Share by Region (2027-2032) Table 36. Global Artificial Intelligence in Drug Discovery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Artificial Intelligence in Drug Discovery Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Artificial Intelligence in Drug Discovery Sales Value Market Share by Country (2021-2026) Table 39. Global Artificial Intelligence in Drug Discovery Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Artificial Intelligence in Drug Discovery Sales Value Market Share by Country (2027-2032) Table 41. IBM Company Information Table 42. IBM Business Overview Table 43. IBM Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. IBM Artificial Intelligence in Drug Discovery Product Portfolio Table 45. IBM Recent Development Table 46. Exscientia Company Information Table 47. Exscientia Business Overview Table 48. Exscientia Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Exscientia Artificial Intelligence in Drug Discovery Product Portfolio Table 50. Exscientia Recent Development Table 51. Google(Alphabet) Company Information Table 52. Google(Alphabet) Business Overview Table 53. Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio Table 55. Google(Alphabet) Recent Development Table 56. Microsoft Company Information Table 57. Microsoft Business Overview Table 58. Microsoft Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Microsoft Artificial Intelligence in Drug Discovery Product Portfolio Table 60. Microsoft Recent Development Table 61. Atomwise Company Information Table 62. Atomwise Business Overview Table 63. Atomwise Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Atomwise Artificial Intelligence in Drug Discovery Product Portfolio Table 65. Atomwise Recent Development Table 66. Schrodinger Company Information Table 67. Schrodinger Business Overview Table 68. Schrodinger Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio Table 70. Schrodinger Recent Development Table 71. Aitia Company Information Table 72. Aitia Business Overview Table 73. Aitia Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Aitia Artificial Intelligence in Drug Discovery Product Portfolio Table 75. Aitia Recent Development Table 76. Insilico Medicine Company Information Table 77. Insilico Medicine Business Overview Table 78. Insilico Medicine Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio Table 80. Insilico Medicine Recent Development Table 81. NVIDIA Company Information Table 82. NVIDIA Business Overview Table 83. NVIDIA Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio Table 85. NVIDIA Recent Development Table 86. XtalPi Company Information Table 87. XtalPi Business Overview Table 88. XtalPi Artificial Intelligence in Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. XtalPi Artificial Intelligence in Drug Discovery Product Portfolio Table 90. XtalPi Recent Development Table 91. BPGbio Company Information Table 92. BPGbio Business Overview Table 93. BPGbio Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. BPGbio Artificial Intelligence in Drug Discovery Product Portfolio Table 95. BPGbio Recent Development Table 96. Owkin Company Information Table 97. Owkin Business Overview Table 98. Owkin Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Owkin Artificial Intelligence in Drug Discovery Product Portfolio Table 100. Owkin Recent Development Table 101. CytoReason Company Information Table 102. CytoReason Business Overview Table 103. CytoReason Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. CytoReason Artificial Intelligence in Drug Discovery Product Portfolio Table 105. CytoReason Recent Development Table 106. Deep Genomics Company Information Table 107. Deep Genomics Business Overview Table 108. Deep Genomics Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio Table 110. Deep Genomics Recent Development Table 111. Cloud Pharmaceuticals Company Information Table 112. Cloud Pharmaceuticals Business Overview Table 113. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio Table 115. Cloud Pharmaceuticals Recent Development Table 116. BenevolentAI Company Information Table 117. BenevolentAI Business Overview Table 118. BenevolentAI Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio Table 120. BenevolentAI Recent Development Table 121. Cyclica Company Information Table 122. Cyclica Business Overview Table 123. Cyclica Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Cyclica Artificial Intelligence in Drug Discovery Product Portfolio Table 125. Cyclica Recent Development Table 126. Verge Genomics Company Information Table 127. Verge Genomics Business Overview Table 128. Verge Genomics Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio Table 130. Verge Genomics Recent Development Table 131. Valo Health Company Information Table 132. Valo Health Business Overview Table 133. Valo Health Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Valo Health Artificial Intelligence in Drug Discovery Product Portfolio Table 135. Valo Health Recent Development Table 136. Envisagenics Company Information Table 137. Envisagenics Business Overview Table 138. Envisagenics Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio Table 140. Envisagenics Recent Development Table 141. Euretos Company Information Table 142. Euretos Business Overview Table 143. Euretos Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Euretos Artificial Intelligence in Drug Discovery Product Portfolio Table 145. Euretos Recent Development Table 146. BioAge Labs Company Information Table 147. BioAge Labs Business Overview Table 148. BioAge Labs Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio Table 150. BioAge Labs Recent Development Table 151. Iktos Company Information Table 152. Iktos Business Overview Table 153. Iktos Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Iktos Artificial Intelligence in Drug Discovery Product Portfolio Table 155. Iktos Recent Development Table 156. BioSymetrics Company Information Table 157. BioSymetrics Business Overview Table 158. BioSymetrics Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio Table 160. BioSymetrics Recent Development Table 161. Evaxion Biotech Company Information Table 162. Evaxion Biotech Business Overview Table 163. Evaxion Biotech Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio Table 165. Evaxion Biotech Recent Development Table 166. Aria Pharmaceuticals, Inc Company Information Table 167. Aria Pharmaceuticals, Inc Business Overview Table 168. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio Table 170. Aria Pharmaceuticals, Inc Recent Development Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Artificial Intelligence in Drug Discovery Product Image Figure 2. Global Artificial Intelligence in Drug Discovery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Drug Discovery Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Intelligence in Drug Discovery Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hardware Image Figure 8. Software Image Figure 9. Service Image Figure 10. Global Artificial Intelligence in Drug Discovery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Artificial Intelligence in Drug Discovery Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Artificial Intelligence in Drug Discovery Sales Value Share by Type (2021-2032) Figure 13. Early Drug Discovery Image Figure 14. Preclinical Phase Image Figure 15. Clinical Phase Image Figure 16. Regulatory Approval Image Figure 17. Global Artificial Intelligence in Drug Discovery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Artificial Intelligence in Drug Discovery Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Artificial Intelligence in Drug Discovery Sales Value Share by Application (2021-2032) Figure 20. Global Artificial Intelligence in Drug Discovery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Artificial Intelligence in Drug Discovery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Artificial Intelligence in Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 23. North America Artificial Intelligence in Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Artificial Intelligence in Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Artificial Intelligence in Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Artificial Intelligence in Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Artificial Intelligence in Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Artificial Intelligence in Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 29. South America Artificial Intelligence in Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
  • Service
Applications
  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval
Companies covered
  • IBM
  • Exscientia
  • Google(Alphabet)
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Intelligence in Drug Discovery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Intelligence in Drug Discovery Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Drug Discovery Market Dynamics
  1. 2.1 Artificial Intelligence in Drug Discovery Industry Trends
  2. 2.2 Artificial Intelligence in Drug Discovery Industry Drivers
  3. 2.3 Artificial Intelligence in Drug Discovery Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Drug Discovery Industry Restraints
3 Artificial Intelligence in Drug Discovery Market by Company
  1. 3.1 Global Artificial Intelligence in Drug Discovery Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Intelligence in Drug Discovery Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Intelligence in Drug Discovery Company Ranking (2024-2026)
  4. 3.4 Global Artificial Intelligence in Drug Discovery Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Intelligence in Drug Discovery Company Product Type and Application
  6. 3.6 Global Artificial Intelligence in Drug Discovery Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Intelligence in Drug Discovery Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence in Drug Discovery Market by Type
  1. 4.1 Artificial Intelligence in Drug Discovery Type Introduction
  2. 4.1.1 Hardware
  3. 4.1.2 Software
  4. 4.1.3 Service
  5. 4.2 Global Artificial Intelligence in Drug Discovery Sales Value by Type
  6. 4.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artificial Intelligence in Drug Discovery Sales Value by Type (2021-2032)
  8. 4.2.3 Global Artificial Intelligence in Drug Discovery Sales Value Share by Type (2021-2032)
5 Artificial Intelligence in Drug Discovery Market by Application
  1. 5.1 Artificial Intelligence in Drug Discovery Application Introduction
  2. 5.1.1 Early Drug Discovery
  3. 5.1.2 Preclinical Phase
  4. 5.1.3 Clinical Phase
  5. 5.1.4 Regulatory Approval
  6. 5.2 Global Artificial Intelligence in Drug Discovery Sales Value by Application
  7. 5.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Artificial Intelligence in Drug Discovery Sales Value by Application (2021-2032)
  9. 5.2.3 Global Artificial Intelligence in Drug Discovery Sales Value Share by Application (2021-2032)
6 Artificial Intelligence in Drug Discovery Regional Value Analysis
  1. 6.1 Global Artificial Intelligence in Drug Discovery Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Intelligence in Drug Discovery Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Intelligence in Drug Discovery Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Intelligence in Drug Discovery Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Intelligence in Drug Discovery Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Intelligence in Drug Discovery Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Intelligence in Drug Discovery Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Intelligence in Drug Discovery Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Intelligence in Drug Discovery Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Intelligence in Drug Discovery Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Intelligence in Drug Discovery Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence in Drug Discovery Country-level Value Analysis
  1. 7.1 Global Artificial Intelligence in Drug Discovery Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Intelligence in Drug Discovery Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Intelligence in Drug Discovery Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Intelligence in Drug Discovery Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Intelligence in Drug Discovery Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Intelligence in Drug Discovery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IBM
  2. 8.1.1 IBM Company Information
  3. 8.1.2 IBM Business Overview
  4. 8.1.3 IBM Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IBM Artificial Intelligence in Drug Discovery Product Portfolio
  6. 8.1.5 IBM Recent Developments
  7. 8.2 Exscientia
  8. 8.2.1 Exscientia Company Information
  9. 8.2.2 Exscientia Business Overview
  10. 8.2.3 Exscientia Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Exscientia Artificial Intelligence in Drug Discovery Product Portfolio
  12. 8.2.5 Exscientia Recent Developments
  13. 8.3 Google(Alphabet)
  14. 8.3.1 Google(Alphabet) Company Information
  15. 8.3.2 Google(Alphabet) Business Overview
  16. 8.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio
  18. 8.3.5 Google(Alphabet) Recent Developments
  19. 8.4 Microsoft
  20. 8.4.1 Microsoft Company Information
  21. 8.4.2 Microsoft Business Overview
  22. 8.4.3 Microsoft Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Microsoft Artificial Intelligence in Drug Discovery Product Portfolio
  24. 8.4.5 Microsoft Recent Developments
  25. 8.5 Atomwise
  26. 8.5.1 Atomwise Company Information
  27. 8.5.2 Atomwise Business Overview
  28. 8.5.3 Atomwise Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Atomwise Artificial Intelligence in Drug Discovery Product Portfolio
  30. 8.5.5 Atomwise Recent Developments
  31. 8.6 Schrodinger
  32. 8.6.1 Schrodinger Company Information
  33. 8.6.2 Schrodinger Business Overview
  34. 8.6.3 Schrodinger Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio
  36. 8.6.5 Schrodinger Recent Developments
  37. 8.7 Aitia
  38. 8.7.1 Aitia Company Information
  39. 8.7.2 Aitia Business Overview
  40. 8.7.3 Aitia Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aitia Artificial Intelligence in Drug Discovery Product Portfolio
  42. 8.7.5 Aitia Recent Developments
  43. 8.8 Insilico Medicine
  44. 8.8.1 Insilico Medicine Company Information
  45. 8.8.2 Insilico Medicine Business Overview
  46. 8.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio
  48. 8.8.5 Insilico Medicine Recent Developments
  49. 8.9 NVIDIA
  50. 8.9.1 NVIDIA Company Information
  51. 8.9.2 NVIDIA Business Overview
  52. 8.9.3 NVIDIA Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio
  54. 8.9.5 NVIDIA Recent Developments
  55. 8.10 XtalPi
  56. 8.10.1 XtalPi Company Information
  57. 8.10.2 XtalPi Business Overview
  58. 8.10.3 XtalPi Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  59. 8.10.4 XtalPi Artificial Intelligence in Drug Discovery Product Portfolio
  60. 8.10.5 XtalPi Recent Developments
  61. 8.11 BPGbio
  62. 8.11.1 BPGbio Company Information
  63. 8.11.2 BPGbio Business Overview
  64. 8.11.3 BPGbio Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BPGbio Artificial Intelligence in Drug Discovery Product Portfolio
  66. 8.11.5 BPGbio Recent Developments
  67. 8.12 Owkin
  68. 8.12.1 Owkin Company Information
  69. 8.12.2 Owkin Business Overview
  70. 8.12.3 Owkin Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Owkin Artificial Intelligence in Drug Discovery Product Portfolio
  72. 8.12.5 Owkin Recent Developments
  73. 8.13 CytoReason
  74. 8.13.1 CytoReason Company Information
  75. 8.13.2 CytoReason Business Overview
  76. 8.13.3 CytoReason Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CytoReason Artificial Intelligence in Drug Discovery Product Portfolio
  78. 8.13.5 CytoReason Recent Developments
  79. 8.14 Deep Genomics
  80. 8.14.1 Deep Genomics Company Information
  81. 8.14.2 Deep Genomics Business Overview
  82. 8.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio
  84. 8.14.5 Deep Genomics Recent Developments
  85. 8.15 Cloud Pharmaceuticals
  86. 8.15.1 Cloud Pharmaceuticals Company Information
  87. 8.15.2 Cloud Pharmaceuticals Business Overview
  88. 8.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio
  90. 8.15.5 Cloud Pharmaceuticals Recent Developments
  91. 8.16 BenevolentAI
  92. 8.16.1 BenevolentAI Company Information
  93. 8.16.2 BenevolentAI Business Overview
  94. 8.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio
  96. 8.16.5 BenevolentAI Recent Developments
  97. 8.17 Cyclica
  98. 8.17.1 Cyclica Company Information
  99. 8.17.2 Cyclica Business Overview
  100. 8.17.3 Cyclica Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cyclica Artificial Intelligence in Drug Discovery Product Portfolio
  102. 8.17.5 Cyclica Recent Developments
  103. 8.18 Verge Genomics
  104. 8.18.1 Verge Genomics Company Information
  105. 8.18.2 Verge Genomics Business Overview
  106. 8.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio
  108. 8.18.5 Verge Genomics Recent Developments
  109. 8.19 Valo Health
  110. 8.19.1 Valo Health Company Information
  111. 8.19.2 Valo Health Business Overview
  112. 8.19.3 Valo Health Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Valo Health Artificial Intelligence in Drug Discovery Product Portfolio
  114. 8.19.5 Valo Health Recent Developments
  115. 8.20 Envisagenics
  116. 8.20.1 Envisagenics Company Information
  117. 8.20.2 Envisagenics Business Overview
  118. 8.20.3 Envisagenics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio
  120. 8.20.5 Envisagenics Recent Developments
  121. 8.21 Euretos
  122. 8.21.1 Euretos Company Information
  123. 8.21.2 Euretos Business Overview
  124. 8.21.3 Euretos Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Euretos Artificial Intelligence in Drug Discovery Product Portfolio
  126. 8.21.5 Euretos Recent Developments
  127. 8.22 BioAge Labs
  128. 8.22.1 BioAge Labs Company Information
  129. 8.22.2 BioAge Labs Business Overview
  130. 8.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  131. 8.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio
  132. 8.22.5 BioAge Labs Recent Developments
  133. 8.23 Iktos
  134. 8.23.1 Iktos Company Information
  135. 8.23.2 Iktos Business Overview
  136. 8.23.3 Iktos Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Iktos Artificial Intelligence in Drug Discovery Product Portfolio
  138. 8.23.5 Iktos Recent Developments
  139. 8.24 BioSymetrics
  140. 8.24.1 BioSymetrics Company Information
  141. 8.24.2 BioSymetrics Business Overview
  142. 8.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio
  144. 8.24.5 BioSymetrics Recent Developments
  145. 8.25 Evaxion Biotech
  146. 8.25.1 Evaxion Biotech Company Information
  147. 8.25.2 Evaxion Biotech Business Overview
  148. 8.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio
  150. 8.25.5 Evaxion Biotech Recent Developments
  151. 8.26 Aria Pharmaceuticals, Inc
  152. 8.26.1 Aria Pharmaceuticals, Inc Company Information
  153. 8.26.2 Aria Pharmaceuticals, Inc Business Overview
  154. 8.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio
  156. 8.26.5 Aria Pharmaceuticals, Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst